We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRHC icon
9376
La Rosa Holding
LRHC
$1.35M
0
PCIG icon
9377
Polen Capital International Growth ETF
PCIG
$28.9M
$539 ﹤0.01%
59
-122
-67% -$1.17K
GLBZ
9378
DELISTED
Glen Burnie Bancorp
GLBZ
$536 ﹤0.01%
+92
New +$527
CRWS icon
9379
Crown Crafts
CRWS
$32.3M
$534 ﹤0.01%
+119
New +$550
AENTW icon
9380
Alliance Entertainment Holding Corp Warrants
AENTW
$532 ﹤0.01%
+901
New +$161
PTIR
9381
GraniteShares 2x Long PLTR Daily ETF
PTIR
$502M
$525 ﹤0.01%
+60
New +$345
STRR
9382
Star Equity Holdings
STRR
$41.7M
$522 ﹤0.01%
40
+39
+3,900% +$576
DRTSW icon
9383
Alpha Tau Medical Warrant
DRTSW
$79.6M
$521 ﹤0.01%
2,483
-317
-11% -$65
FBUF icon
9384
Fidelity Dynamic Buffered Equity ETF
FBUF
$24.2M
$518 ﹤0.01%
19
-37
-66% -$1.01K
GOVZ icon
9385
iShares 25+ Year Treasury STRIPS Bond ETF
GOVZ
$261M
$514 ﹤0.01%
+13
New +$560
ASBP
9386
Aspire Biopharma
ASBP
$10M
0
SATLW icon
9387
Satellogic Inc Warrant
SATLW
$79M
$509 ﹤0.01%
1,386
-1,412
-50% -$334
LABD icon
9388
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$57.2M
$508 ﹤0.01%
7
-2,239
-100% -$137K
NRXPW
9389
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$501 ﹤0.01%
3,911
-11,340
-74% -$704
GAME icon
9390
GameSquare
GAME
$37.3M
$500 ﹤0.01%
606
-250
-29% -$209
NKGN
9391
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$500 ﹤0.01%
763
-13,883
-95% -$5.66K
LUCYW icon
9392
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$123K
$498 ﹤0.01%
+11,315
New +$468
BULD icon
9393
Pacer BlueStar Engineering the Future ETF
BULD
$16.2M
$492 ﹤0.01%
23
+7
+44% +$152
SY
9394
So-Young International
SY
$219M
$492 ﹤0.01%
592
+558
+1,641% +$505
BAYAR
9395
DELISTED
Bayview Acquisition Corp Right
BAYAR
$487 ﹤0.01%
+4,826
New +$808
CHMI
9396
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
$486 ﹤0.01%
184
-273
-60% -$820
TSLG
9397
Leverage Shares 2X Long TSLA Daily ETF
TSLG
$35.6M
$486 ﹤0.01%
+36
New +$588
RVMDW icon
9398
Revolution Medicines Inc Warrant
RVMDW
$127M
$485 ﹤0.01%
2,692
+2,664
+9,514% +$788
DYAI icon
9399
Dyadic International
DYAI
$36.4M
$480 ﹤0.01%
+274
New +$374
CYCUW
9400
Cycurion Inc Warrant
CYCUW
$311K
$480 ﹤0.01%
28,228
-100
-0.4% -$2

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.